サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1285023

医薬品開発業務受託機関（CRO）サービス市場：動向、機会、競合分析【2023年～2028年】

Contract Research Organization (CRO) Services Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

医薬品開発業務受託機関（CRO）サービス市場：動向、機会、競合分析【2023年～2028年】
出版日: 2023年05月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

医薬品開発業務受託機関（CRO）サービスの市場動向と予測

世界の医薬品開発業務受託機関（CRO）サービス市場は、2023年から2028年までのCAGRが10.1%で、2028年までに推定1,161億米ドルに達すると予測されています。この市場の主な促進要因は、医薬品の研究開発活動に対するニーズの高まり、臨床試験件数の増加、製薬企業の研究活動を支援するための民間および公的資金の増加です。世界の医薬品開発業務受託機関（CRO）サービス市場の将来は、製薬・バイオ医薬品企業、医療機器企業、学術機関市場などでのビジネスチャンスが期待できそうです。

医薬品開発業務受託機関（CRO）サービス企業一覧

市場参加企業は、提供する製品の品質に基づいて競争しています。この市場の主要企業は、製造施設の拡大、研究開発投資、インフラ整備、バリューチェーン全体における統合機会の活用に注力しています。これらの戦略により、医薬品開発業務受託機関（CRO）サービス企業は、需要の増加への対応、競争力の確保、革新的な製品・技術の開発、製造コストの削減、顧客基盤の拡大などを実現しています。

医薬品開発業務受託機関（CRO）サービスの市場洞察

  • Lucintelは、慢性疾患の患者数の増加、医薬品の研究開発パイプラインの規模拡大、正確かつ迅速な疾患検出のための高額な臨床試験費用などにより、予測期間中、臨床サービスが最大のセグメントを維持すると予測しています。
  • この市場において、製薬企業・バイオ医薬品企業は、臨床試験実施のためのCROとの戦略的提携の増加や、製薬会社の成長を促進する有利な政府プログラムにより、最大のセグメントを維持すると予想されます。
  • 北米は、ヘルスケア分野への投資の増加や、慢性疾患の治療に有効な薬剤を継続的に研究するためのCROサービスに対する需要の増加により、引き続き最大の地域であると予想されます。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長すると思うか、またその理由は？
  • Q.3.どの地域がより速いペースで成長すると思うか、またその理由は？
  • Q.4.市場力学に影響を与える主要因は何か？この市場における主な課題とビジネスリスクは何か？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は何か？
  • Q.6.この市場における新たな動向とその理由は何か？
  • Q.7.この市場における顧客の要求の変化にはどのようなものがあるか？
  • Q.8.市場における新たな開発は何か？これらの開発をリードしているのはどの企業か？
  • Q.9.この市場における主要なプレーヤーは誰か？主要プレーヤーは事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替別市場シェア損失の脅威はどの程度あるのか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の医薬品開発業務受託機関（CRO）サービス市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の推進力と課題

第3章 2017年から2028年までの市場動向と予測分析

  • マクロ経済動向（2017～2022年）と予測（2023～2028年）
  • 世界の医薬品開発業務受託機関（CRO）サービス市場の動向（2017～2022年）と予測（2023～2028年）
  • サービスタイプ別の世界の医薬品開発業務受託機関（CRO）サービス市場
    • 発見
    • 前臨床
    • 臨床
    • 検査サービス
  • 用途別の世界の医薬品開発業務受託機関（CRO）サービス市場
    • 腫瘍
    • 心臓病
    • 感染症
    • 代謝障害
    • その他
  • 最終用途産業別の世界の医薬品開発業務受託機関（CRO）サービス市場
    • 製薬企業・バイオ医薬品企業
    • 医療機器企業
    • 学術機関

第4章 2017年から2028年までの地域別の市場動向と予測分析

  • 地域別の医薬品開発業務受託機関（CRO）サービス市場
  • 北米の医薬品開発業務受託機関（CRO）サービス市場
  • 欧州の医薬品開発業務受託機関（CRO）サービス市場
  • アジア太平洋の医薬品開発業務受託機関（CRO）サービス市場
  • その他の地域の医薬品開発業務受託機関（CRO）サービス市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 事業統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • サービスタイプ別の世界の医薬品開発業務受託機関（CRO）サービス市場の成長機会
    • 用途別の世界の医薬品開発業務受託機関（CRO）サービス市場の成長機会
    • 最終用途産業別の世界の医薬品開発業務受託機関（CRO）サービス市場の成長機会
    • 地域別の世界の医薬品開発業務受託機関（CRO）サービス市場の成長機会
  • 世界の医薬品開発業務受託機関（CRO）サービス市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の医薬品開発業務受託機関（CRO）サービス市場の能力拡大
    • 世界の医薬品開発業務受託機関（CRO）サービス市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業プロファイル

  • BIO Agile Therapeutics
  • Novotech Health Holding
  • Parexel
  • Firma Clinical Research
  • IQVIA
  • ICON PLC
  • Envigo
  • Charles River
目次

Contract Research Organization (CRO) Services Market Trends and Forecast

The future of the global contract research organization (CRO) services market looks promising with opportunities in the pharmaceutical & biopharmaceutical companies, medical device companies, and academic institute markets. The global contract research organization (CRO) services market is expected to reach an estimated $116.1 billion by 2028 with a CAGR of 10.1% from 2023 to 2028. The major drivers for this market are increasing need for research and development activity for drugs, rising number of clinical trial, and growing private and public funding to support research activities of pharmaceutical industries.

A more than 150-page report is developed to help in your business decisions.

Contract Research Organization (CRO) Services Market by Segment

The study includes a forecast for the global contract research organization (CRO) services market by service type, application, end use industry, and region, as follows:

Contract Research Organization (CRO) Services Market by Service Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Discovery
  • Pre-clinical
  • Clinical
  • Laboratory Services

Contract Research Organization (CRO) Services Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Oncology
  • Cardiology
  • Infectious Disease
  • Metabolic Disorders
  • Others

Contract Research Organization (CRO) Services Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes

Contract Research Organization (CRO) Services Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Contract Research Organization (CRO) Services Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies contract research organization (CRO) services companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the contract research organization (CRO) services companies profiled in this report include.

  • BIO Agile Therapeutics
  • Novotech Health Holding
  • Parexel
  • Firma Clinical Research
  • IQVIA
  • ICON PLC
  • Envigo
  • Charles River

Contract Research Organization (CRO) Services Market Insights

  • Lucintel forecasts that clinical services will remain the largest segment over the forecast period due to growing cases of chronic diseases, increasing size of the R&D pipeline of drugs and high clinical trial expenses for precise and speedy disease detection.
  • Within this market, pharmaceutical & biopharmaceutical company segment is expected to remain the largest segment due to increasing pharmaceutical company strategic alliances with CRO to conduct clinical trials and favorable government programs to foster the growth of pharmaceutical firms.
  • North America is expected to remain the largest region due to growing investment in the healthcare sector and increasing demand for CRO services to continuously research on effective medications to treat chronic diseases in the region.

Features of the Contract Research Organization (CRO) Services Market

  • Market Size Estimates: Contract research organization (CRO) services market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Contract research organization (CRO) services market size by various segments, such as by service type, application, end use industry, and region
  • Regional Analysis: Contract research organization (CRO) services market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by service type, application, end use industry, and regions for the contract research organization (CRO) services market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the contract research organization (CRO) services market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the contract research organization (CRO) services market size?

Answer: The global contract research organization (CRO) services market is expected to reach an estimated $116.1 billion by 2028.

Q2. What is the growth forecast for contract research organization (CRO) services market?

Answer: The global contract research organization (CRO) services market is expected to grow with a CAGR of 10.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the contract research organization (CRO) services market?

Answer: The major drivers for this market are increasing need for research and development activity for drugs, rising number of clinical trial, and growing private and public funding to support research activities of pharmaceutical industries.

Q4. What are the major segments for contract research organization (CRO) services market?

Answer: The future of the contract research organization (CRO) services market looks promising with opportunities in the pharmaceutical & biopharmaceutical companies, medical device companies, and academic institute markets.

Q5. Who are the key contract research organization (CRO) services companies?

Answer: Some of the key contract research organization (CRO) services companies are as follows:

  • BIO Agile Therapeutics
  • Novotech Health Holding
  • Parexel
  • Firma Clinical Research
  • IQVIA
  • ICON PLC
  • Envigo
  • Charles River

Q6. Which contract research organization (CRO) services segment will be the largest in future?

Answer:Lucintel forecasts that clinical services will remain the largest segment over the forecast period due to growing size of the R&D pipeline of drugs and high clinical trial expenses and increased chances of chronic diseases which is influencing the requirement for precise and speedy disease detection.

Q7. In contract research organization (CRO) services market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to remain the largest region due to growing investment in the healthcare sector and increasing demand for CRO services to continuously research on effective medications to treat chronic diseases in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the contract research organization (CRO) services market by service type (discovery, pre-clinical, clinical, and laboratory services), application (oncology, cardiology, infectious diseases, metabolic disorders, and others), end use industry (pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

Table of Contents

1. Executive Summary

2. Global Contract Research Organization (CRO) Services Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Contract Research Organization (CRO) Services Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Contract Research Organization (CRO) Services Market by Service Type
    • 3.3.1: Discovery
    • 3.3.2: Pre-clinical
    • 3.3.3: Clinical
    • 3.3.4: Laboratory Services
  • 3.4: Global Contract Research Organization (CRO) Services Market by Application
    • 3.4.1: Oncology
    • 3.4.2: Cardiology
    • 3.4.3: Infectious Disease
    • 3.4.4: Metabolic Disorders
    • 3.4.5: Others
  • 3.5: Global Contract Research Organization (CRO) Services Market by End Use Industry
    • 3.5.1: Pharmaceutical & Biopharmaceutical Companies
    • 3.5.2: Medical Device Companies
    • 3.5.3: Academic Institutes

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Contract Research Organization (CRO) Services Market by Region
  • 4.2: North American Contract Research Organization (CRO) Services Market
    • 4.2.1: North American Contract Research Organization (CRO) Services Market by Service Type: Discovery, Pre-Clinical, Clinical, and Laboratory Services
    • 4.2.2: North American Contract Research Organization (CRO) Services Market by End Use Industry: Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes
  • 4.3: European Contract Research Organization (CRO) Services Market
    • 4.3.1: European Contract Research Organization (CRO) Services Market by Service Type: Discovery, Pre-Clinical, Clinical, and Laboratory Services
    • 4.3.2: European Contract Research Organization (CRO) Services Market by End Use Industry: Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes
  • 4.4: APAC Contract Research Organization (CRO) Services Market
    • 4.4.1: APAC Contract Research Organization (CRO) Services Market by Service Type: Discovery, Pre-Clinical, Clinical, and Laboratory Services
    • 4.4.2: APAC Contract Research Organization (CRO) Services Market by End Use Industry: Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes
  • 4.5: ROW Contract Research Organization (CRO) Services Market
    • 4.5.1: ROW Contract Research Organization (CRO) Services Market by Service Type: Discovery, Pre-Clinical, Clinical, and Laboratory Services
    • 4.5.2: ROW Contract Research Organization (CRO) Services Market by End Use Industry: Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Contract Research Organization (CRO) Services Market by Service Type
    • 6.1.2: Growth Opportunities for the Global Contract Research Organization (CRO) Services Market by Application
    • 6.1.3: Growth Opportunities for the Global Contract Research Organization (CRO) Services Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Contract Research Organization (CRO) Services Market by Region
  • 6.2: Emerging Trends in the Global Contract Research Organization (CRO) Services Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Contract Research Organization (CRO) Services Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Contract Research Organization (CRO) Services Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: BIO Agile Therapeutics
  • 7.2: Novotech Health Holding
  • 7.3: Parexel
  • 7.4: Firma Clinical Research
  • 7.5: IQVIA
  • 7.6: ICON PLC
  • 7.7: Envigo
  • 7.8: Charles River